A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: Results of a safety run-in-A trial of the ECOG-ACRIN Cancer Research Group (EA2174). Eads, J., Weitz, M., Catalano, P. J., Gibson, M. K., Rajdev, L., Khullar, O., Lin, S. H., Gatsonis, C., Wistuba, I., Sanjeevaiah, A., Benson, A., Bahary, N., Spencer, K., Saba, N. F., Hamilton, S. R., Staley, C. A., Chakravarthy, B., Fisher, G. A., Wong, T. Z., O'Dwyer, P. J. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.4064

View details for Web of Science ID 000708120602164